GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » 5-Year Yield-on-Cost %

Replek AD (XMAE:REPL) 5-Year Yield-on-Cost % : 1.94 (As of Apr. 24, 2025)


View and export this data going back to . Start your Free Trial

What is Replek AD 5-Year Yield-on-Cost %?

Replek AD's yield on cost for the quarter that ended in Dec. 2024 was 1.94.


The historical rank and industry rank for Replek AD's 5-Year Yield-on-Cost % or its related term are showing as below:

XMAE:REPL' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.12   Med: 5.15   Max: 7.16
Current: 1.94


During the past 13 years, Replek AD's highest Yield on Cost was 7.16. The lowest was 1.12. And the median was 5.15.


XMAE:REPL's 5-Year Yield-on-Cost % is ranked worse than
55.66% of 512 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs XMAE:REPL: 1.94

Competitive Comparison of Replek AD's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Replek AD's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Replek AD's 5-Year Yield-on-Cost % falls into.


;
;

Replek AD 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Replek AD is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Replek AD  (XMAE:REPL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Replek AD 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Replek AD's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Replek AD Business Description

Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.